Alzamend Neuro, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Alzamend Neuro, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2023.
  • Alzamend Neuro, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending July 31, 2024 was $1.96M.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.65M.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $200.000.
  • Alzamend Neuro, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $18.9M, a 324% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.65M +$3.65M May 1, 2023 Apr 30, 2024 10-K 2024-07-30
2022 $200* -$18.9M May 1, 2022 Apr 30, 2023 10-K 2024-07-30
2021 $18.9M +$14.4M +324% May 1, 2021 Apr 30, 2022 10-K 2023-07-27
2020 $4.45M +$2.16M +94.5% May 1, 2020 Apr 30, 2021 10-K 2022-07-19
2019 $2.29M May 1, 2019 Apr 30, 2020 10-K 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.